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improved to 38.9 at two years. For cementless UKR the pre-operative
OKS was 24.4/48 which improved to 41.9 at two years. There was no
signiﬁcant difference (p¼0.225, Mann-Whitney).
Conclusions: Cementless Oxford UKR has equivalent clinical outcome
in the short term to the proven cemented prosthesis. It has an increased
amount of tibial migration, expressed as subsidence, compared to
cemented ﬁxation, but there is early stabilisation and no further
migration after six months. This suggests that the particular kinematics
of the Oxford UKR allow a mechanical environment under which
a hydroxyapatite coated prosthesis can gain secure ﬁxation that should
provide very long term survivorship.
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CLINICAL OUTCOME AFTER TOTAL KNEE REPLACEMENT:
FORGOTTEN KNEE. A SINGLE-CENTRE PROSPECTIVE PRAGMATIC
STUDY
M. Bercovy, Sr. 1, X. Chevalier, Sr. 2. 1Hosp. Henri Mondor, Centre Medical
Vauban, Paris, France; 2Hosp. Henri Mondor, Creteil, France
Purpose: Total knee replacement is the radical surgical treatment of
knee osteoarthritis and usually produces good or very good results in
terms of pain and function. However the patient may report that the
knee, although free of pain, does not feel normal. As a result, the
patient's assessment may be less favourable than the surgeon's
assessment of the outcome. A “forgotten” knee is a joint that feels
completely normal to the patient and is therefore the best possible
outcome from the patient's viewpoint.
To evaluate the prevalence of “forgotten knee” in a single-centre
pragmatic prospective study of a uniform patient population, from
January 2001 to December 2008.
Methods: The study patients were selected for TKR by a specialized
surgeon based on tibiofemoral and/or patellofemoral knee osteoar-
thritis stage IV in the Alback radiological classiﬁcation, with a >70-mm
visual-analogue-scale (VAS) pain score and non response to appropriate
medical management. All procedures were done by the same surgeon
(MB). A mobile-bearing posterior cruciate ligament-substituting pros-
thesis was used. The following were recorded at baseline and during
regular post-surgery visits: VAS pain score, Knee Society knee and
function scores, and four functional scores (KOOS, Oxford, WOMAC, andLequesne). Forgotten knee was assessed at last follow-up based on the
patient's answer to the following question: “Do you feel your knee is
completely normal all the time?” Knee radiograph ﬁndings before and
after TKR were recorded. The chi-square test was used for qualitative
parameters and the t test and analysis of variance for quantitative
parameters.
Results:We included 498 knees in 406 patients (63% of women). Mean
age was 708.6 years, mean body mass index was 29 Kg/m2 , and mean
follow-up was 6.4 (3-10) years. Varus deformity was noted in 63% and
valgus deformity in 36% of patients. At last follow-up, 375 patients were
still active. All functional scores improved signiﬁcantly (p<0.001) from
baseline to last follow-up: KOSS, 4014 to 959; Oxford, 389 to 144;
global WOMAC, 5118 to 127; and Lequesne, 149 to 13. Among the
patients, 80% felt satisﬁed with the procedure and 87% felt the results
were consistent with their expectations, but only 44% met our criterion
for “forgotten” knee. There were 17 complications (3.4%) including 5
cases of sepsis with favourable outcomes after reoperation.
Conclusions: Only 44% of patients had a forgotten knee after TKR,
although 80% were satisﬁed and free of pain. A forgotten knee may be
a criterion for complete recovery that might be of use in future studies
of TKR outcomes.
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ASSOCIATIONS BETWEEN PRE-OPERATIVE RADIOGRAPHIC CHANGES
AND OUTCOMES AFTER TOTAL KNEE JOINT REPLACEMENT FOR
OSTEOARTHRITIS
M. Dowsey 1, M. Nikpour 1, P. Choong 1, P. Dieppe 2. 1 St Vincent's Hosp.,
Melbourne, Australia; 2 Peninsula Med. Sch., Plymouth, United Kingdom
Purpose: Knee joint replacement (KJR) for OA is a successful inter-
vention, but about 20% of KJR patients obtain little or no improvement.
The reasons for this are unclear. The purpose of this study was to
investigate whether pre-operative radiographic changes predict pain
and functional outcomes.
Methods: Data from a prospective single-centre cohort study of
patients undergoing TJR between Jan 1st 2006 and Dec 31st 2007 were
analysed (n ¼ 525). Pre-operative data collection included demo-
graphics (age, sex , BMI, self-reported co-morbidities), the International
Knee Society Score (IKSS), and the Short Form Health Survey (SF-12).
Pre-operative (within 6 months of surgery) AP standing and lateral
radiographs were read by a single observer using the Kellgren and
Laurence (K&L) and Altman atlases, and the scoring repeated on
a random 10% sample to assess rater reliability. Post-operative data
collection at 12 and 24 months included the IKSS and SF-12. Linear and
logistic regression analyses were undertaken to assess the relationships
between baseline radiographic features and pre and post-operative
pain and function.
Results: Of the 525 cases 24 were excluded as they had undergone uni-
compartmental replacements, and 23 radiographs were rejected,
leaving 478 TJR cases for inclusion. 5 and 24 were unable to complete
the 12 or 24 month data respectively due to death, loss to follow-up or
refusal. The amount of missing data was well below 5%.
The mean age of the subjects was 70.8 years (+/- 8.3), 69% were female
and the mean BMI was 32.2.
Pain scores improved from a mean of 4.0(+/-7.3) to 34.9 at 12 months
and 34.8 (+/- 15.9) at 24 months; however about 30% of patients still
complained of moderate or severe pain in the operated knee at each
time point. Function scores improved from amean of 37.5 (+/- 18.1) pre-
operatively to 58.8 and 55.5 (+/- 26.8) at one and two years respectively.
Inter-rater reliability scores for radiographic features were satisfactory,
ranging from a kappa of 0.80 (lateral joint space narrowing) to 0.65
(lateral osteophyte score). The majority had OA K&L grade 3 (57 with
mild (3a) and 200 with severe (3b) JSN) or 4 (87 without (4a) and 119
with (4b) bone attrition). The commonest compartmental distributions
were medial and patella-femoral (244), or medial only (104).
There were no signiﬁcant associations between pre-operative radio-
graphic scores and pre-operative pain or function, but radiographic
severity was associated with outcome. Those with lower K&L grades
and less compartmental involvement were less likely to have obtained
improvements in pain at either 12 or 24 months (e.g. the odds ratio for
ongoing pain in the operated joint at 12 months comparing those with
K&L grades<3 to thosewith grade 4bwas 5.23 (CI 1.5 to 17.6), p¼0.008).
The relationships between pre-operative radiographs and function
were similar but less strong. Outcome did not appear to differ for those
with predominant medial, lateral or patella-femoral joint involvement.
Abstracts / Osteoarthritis and Cartilage 20 (2012) S10–S53S38Multivariate analyses showed that other signiﬁcant, independent
determinants of improvement in pain and function included age,
mental function score of the SF-12 and pre-operative pain and function
(both pain and function), as well as gender and BMI (function only).
Conclusions: The data suggest that we should exercise caution when
considering surgery for patients with severe pain but mild radio-
graphic changes, and conversely, that those with severe joint
damage, irrespective of which compartments are involved, are more
likely to respond well to surgery. A possible explanation for this is
that in those with severe pain and mild joint damage the pain is
driven more by central sensitisation than by any nociceptive input
from the joint.
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A 2-YEAR RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
MULTICENTER STUDY OF AN ORAL SELECTIVE INOS INHIBITOR IN
SUBJECTS WITH SYMPTOMATIC OSTEOARTHRITIS OF THE KNEE
M.-P. Hellio le Graverand-Gastineau 1, R. Clemmer 1, P. Redifer 1,
R.M. Brunell 1, C.W. Hayes 2, K. Brandt 3, S.B. Abramson 4,
P.T. Manning 5, C.G. Miller 6, E. Vignon 7. 1 Pﬁzer Inc, Primary Care
Med.s Dev. Group, Groton, CT, USA; 2Virginia Commonwealth Univ.
Hlth.System, Richmond, VA, USA; 3Kansas Univ. Med. Ctr., Kansas City,
KS, USA; 4New York Sch. of Med., New York, NY, USA; 5Vasculox, Inc, St
Louis, MO, USA; 6BioClinica Inc, Newtown, PA, USA; 7Claude Bernard
Univ., Lyon, France
Purpose: To determine whether inhibition of inducible nitric oxide
synthase (iNOS) can slow progression of knee osteoarthritis (OA), using
the rate of joint space narrowing (JSN) in the medial tibiofemoral
compartment as the primary outcome measure.
Methods: This was a 2-year multinational, multicenter, double-blind,
parallel group trial enrolling subjects with symptomatic knee OA in
which subjects were randomly assigned to receive once daily 50 mg or
200 mg of the selective iNOS inhibitor, SD-6010, or placebo. Subjects
were required to have a bodymass index (BMI)25 and 40 kg/m2 and
Kellgren and Lawrence Grade (KLG) 2 or 3 in the study knee.
Randomization was stratiﬁed by KLG. Radiographs were acquired using
the modiﬁed Lyon-schuss protocol, at baseline, 48 and 96 weeks for
measuring JSN. Clinical beneﬁt was recorded at 12-week then every 24
weeks; use of acetaminophen, NSAIDs and/or weak opioids was
permitted throughout the trial. The primary analysis of the rate of JSN
used a continuous time random coefﬁcients MMRM model. The slope
over the entire 96 week period was used to assess the rate of change in
joint space width (JSW).
Results: Of 1457 randomized subjects (SD-6010 50mg, n¼485; SD-6010
200mg, n¼486; placebo, n¼486), 1048 (71.9%) completed the study.
Subjects were predominantly female (76.5%) with mean age 61.
0 years and mean BMI of 31.8 kg/m2. Fifty-six percent had KLG3. The
primary analysis did not demonstrate the superiority of SD-6010 in
either treatment group over placebo. In an exploratory discrete time
MMRM analysis of KLG2 subjects, the loss of JSW after 48 weeks was
signiﬁcantly smaller with SD-6010 (50 mg or 200 mg) than placebo.
Least squared (LS) mean  standard error (SE) losses in JSW for SD-
6010 50mg (-0.048  0.028 mm) and 200mg (-0.062  0.028 mm)
were 59.9% (95% CI: 6.8%, 106.9%) and 48.7% (95% CI: -8.4%, 93.9%) of
placebo (-0.120  0.028 mm; P¼0.032 and P¼0.081, respectively).
After 96 weeks, the LS mean losses in JSW for SD-6010 50mg (-0.132
 0.036 mm) and 200mg (-0.156  0.037 mm) were 20.9% (95% CI:
-50.5%, 64.0%) and 6.8% (95% CI: -72.7%, 51.7%) of the LS-mean JSW
loss in the placebo group (-0.1670.036 mm) (P¼0.460 and P¼0.812,
respectively). In a similar analysis of KLG3 subjects, no improvement
in JSN was observed. Although SD-6010 showed no efﬁcacy with
respect to improvement in joint pain or function, it was generally safe
and well tolerated in this population.
Conclusions:During the ﬁrst 48 weeks of treatment, subjects with mild
OA who were treated with an iNOS inhibitor had a lower rate of JSN;
however, this improvement was not sustained at 96 weeks. iNOS
inhibition did not slow OA progression in subjects with more severe
radiographic OA. The observed early effect on JSN in subjects with mild
OA supports the role of iNOS in OA pathogenetic mechanisms. However,
the loss of efﬁcacy over time and the lack of effect in subjects with more
severe disease suggest that alternative biochemical catabolic pathways
overcame the effects of nitric oxide inhibition alone or that in more
severe radiographic OA, biomechanical factors may not be amenable to
iNOS inhibition.57
INFLAMMATORY BIOMARKERS OF OA, IL-6 AND LEPTIN ARE
MODIFIABLE IN OVERWEIGHT/OBESE OA PATIENTS WITH
A PROTOCOL THAT COMBINES TRAINING IN PAIN COPING SKILLS
AND WEIGHT MANAGEMENT
J.L. Huebner, L.R. Landerman, T.J. Somers, V.B. Kraus, F. Guilak,
J.A. Blumenthal, D.S. Caldwell, J.R. Rice, F.J. Keefe. Duke Univ. Med. Ctr.,
Durham, NC, USA
Purpose: A randomized clinical trial to investigate the effect of
a combined pain coping skills training and lifestyle behavioral weight
management protocol, on knee pain and disability as well as systemic
biochemical markers, in overweight and obese patients with knee
osteoarthritis.
Methods: Eligibility for the OA LIFE study enrolled participants with
self-reported knee pain who were overweight or obese, met the ACR
criteria for knee OA, and had radiographic evidence of OA in at least one
knee. A total of 232 participants were enrolled in the study and
randomized to one of four treatment groups:1) pain coping skills
training alone (PCST-only), 2) behavioral weight loss alone (BWL-only)
3) PCST with BWL (PCST+BWL), or 4) standard care control (SC). Blood
and urine were collected for biomarker analyses and questionnaires
obtained to assess pain, physical disability, stiffness, activity, psycho-
logical disability (WOMAC, AIMS). Following a 24 week treatment
period, 63 of the participants dropped out prior to completing the
treatment protocol. The remaining 169 subjects completed a post-
treatment clinical assessment and biospecimen collection. Samples
were analyzed for inﬂammatorymarkers (hsCRP, IL-1ra, IL-1b, IL-6, IL-8,
TNF-a, TNFR1 and TNFRII), adipokines (leptin and adiponectin), and
joint biomarkers (HA) by immunoassay. Data are reported as mean (SD)
and theWilcoxon test used to compare biomarker levels at baseline and
after treatment. Values for cytokines were log transformed and corre-
lations were tested with Pearson correlation test. Multivariable
regression analysis was used to assess the effects of treatment group on
the change in biomarker levels during treatment and adjusted for age,
race, gender, and BMI. All analyses were performed using SAS and a p
value of <0.05 was considered statistically signiﬁcant.
Results: Our study population consisted of 169 overweight or obese
patients who were 83% female, 60% white, having a mean (SD) age of
58.70 (10.0) years and a mean (SD) BMI of 34.10 (4.42) at baseline. As
reported previously, patients randomized to PCST+ BWM demonstrated
signiﬁcantly better treatment outcomes in terms of pain and weight
loss when compared to the other three conditions (p¼ <0.05). Analyses
conducted for the present paper comparing mean biomarker levels
before and after treatment revealed signiﬁcant reductions in levels of
hsCRP (p¼0.0014), IL-6 (p¼0.0075), and leptin (p¼0.0001) for the
combined intervention group (PCST+BWL). Adjusting for age, race,
gender, BMI, and baseline biomarker concentration, there were signif-
icant reductions in leptin (b¼-0.19175, p¼0.0120) and IL-6 (b¼-0.25036,
p¼0.0232) in response to only the combined PCST+BWL treatment.
Reductions in both IL-6 and leptin, regardless of the treatment group,
were signiﬁcantly associated with a reduction in WOMAC pain scores.
Changes in IL-6 were also signiﬁcantly associated with changes in
WOMAC physical function score (r¼0.198, p¼0.014) and AIMS physical
disability score (r¼0.192, p¼0.018) and changes in leptin were signiﬁ-
cantly associated with changes in AIMS pain score (r¼0.165, p¼0.040).
Conclusions: This is the ﬁrst study to investigate the effects of
combined pain coping skills training and behavioral weight manage-
ment protocol on biomarkers of inﬂammation in overweight and obese
OA patients. Participants receiving this protocol were not only
successful in signiﬁcantly reducing their pain and weight, but this was
accompanied by signiﬁcant reductions in inﬂammatory markers with
known associations with OA severity. The signiﬁcant reduction in
weight experienced by the combined treatment group is likely the
source of the changes in inﬂammatory state, as adipose tissue is
a known source of inﬂammatory cytokines/adipokines, such as IL-6 and
leptin. This study demonstrated that this inﬂammatory state can be
successfully modiﬁed with behavioral intervention resulting in positive
clinical outcomes.
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ABNORMAL PROCESSING OF TYPE II COLLAGEN IN CARTILAGE-
SPECIFIC SITE-1 PROTEASE KNOCKOUT MICE
D. Patra, E. DeLassus, J. Mueller, L.J. Sandell. Washington Univ. Sch. of
Med., St. Louis, MO, USA
